Try our beta test site

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Rabin Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Rabin Medical Center Identifier:
First received: January 2, 2007
Last updated: January 3, 2007
Last verified: December 2006
Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Condition Intervention Phase
Heart Failure
Drug: erythropoietin
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Resource links provided by NLM:

Further study details as provided by Rabin Medical Center:

Estimated Enrollment: 10
Study Start Date: January 2007
Estimated Study Completion Date: January 2008

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Ischemic heart disease
  • Systolic lv dysfunction
  • Mild anemia
  • Normal renal function
  • Stable condition

Exclusion Criteria:

  • Pregnancy
  • Unstable condition
  • Under 18 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00418119

Cardiology Department, Rabin Medical Center
Petah Tikva, Israel, 49100
Sponsors and Collaborators
Rabin Medical Center
Principal Investigator: Tuvia Ben Gal, MD Cardiology Department Rabin medical Center
Study Director: Ofer Shpilberg, Prof. Hematology Department Rabin Medical Center
Study Director: Daniel Murninkas, MD Cardiology Department Rabin Medical Center
  More Information Identifier: NCT00418119     History of Changes
Other Study ID Numbers: 4273 
Study First Received: January 2, 2007
Last Updated: January 3, 2007

Additional relevant MeSH terms:
Heart Failure
Ventricular Dysfunction, Left
Ventricular Dysfunction
Heart Diseases
Cardiovascular Diseases
Epoetin Alfa
Hematinics processed this record on February 20, 2017